Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amyotrophic Lateral Sclerosis | 77 | 2024 | 1473 | 13.080 |
Why?
|
Phenylbutyrates | 5 | 2024 | 72 | 3.220 |
Why?
|
Motor Neuron Disease | 7 | 2022 | 98 | 2.560 |
Why?
|
Taurochenodeoxycholic Acid | 2 | 2020 | 35 | 1.430 |
Why?
|
Uric Acid | 6 | 2023 | 806 | 1.300 |
Why?
|
Neuroprotective Agents | 4 | 2022 | 957 | 1.130 |
Why?
|
Neurodegenerative Diseases | 7 | 2023 | 1094 | 1.100 |
Why?
|
Low Back Pain | 3 | 2019 | 989 | 1.050 |
Why?
|
Electrodiagnosis | 2 | 2018 | 149 | 0.950 |
Why?
|
Evidence-Based Practice | 2 | 2018 | 499 | 0.910 |
Why?
|
Shoulder Pain | 2 | 2018 | 152 | 0.890 |
Why?
|
Evidence-Based Medicine | 7 | 2021 | 3707 | 0.890 |
Why?
|
Exercise Therapy | 3 | 2020 | 941 | 0.860 |
Why?
|
Disease Progression | 18 | 2024 | 13646 | 0.810 |
Why?
|
Telemedicine | 7 | 2020 | 3107 | 0.730 |
Why?
|
Patient Education as Topic | 3 | 2021 | 2337 | 0.730 |
Why?
|
Muscle Stretching Exercises | 1 | 2020 | 37 | 0.700 |
Why?
|
Practice Guidelines as Topic | 5 | 2019 | 7453 | 0.610 |
Why?
|
Teaching Materials | 1 | 2018 | 86 | 0.590 |
Why?
|
Videoconferencing | 1 | 2019 | 209 | 0.550 |
Why?
|
Humans | 126 | 2024 | 768298 | 0.520 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 4 | 2009 | 43 | 0.510 |
Why?
|
Clinical Trials as Topic | 10 | 2023 | 8051 | 0.510 |
Why?
|
Myositis, Inclusion Body | 1 | 2017 | 145 | 0.500 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2018 | 271 | 0.500 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2018 | 260 | 0.490 |
Why?
|
Double-Blind Method | 11 | 2024 | 12457 | 0.480 |
Why?
|
Burnout, Professional | 4 | 2024 | 712 | 0.480 |
Why?
|
Neuromuscular Diseases | 1 | 2017 | 261 | 0.470 |
Why?
|
Physical Therapy Modalities | 1 | 2018 | 533 | 0.470 |
Why?
|
Porphyrias | 1 | 2014 | 57 | 0.470 |
Why?
|
Robotics | 4 | 2023 | 817 | 0.460 |
Why?
|
Brachial Plexus Neuritis | 1 | 2014 | 21 | 0.460 |
Why?
|
Myositis | 1 | 2017 | 276 | 0.450 |
Why?
|
Motor Skills | 1 | 2017 | 523 | 0.450 |
Why?
|
Median Nerve | 1 | 2014 | 133 | 0.430 |
Why?
|
Biological Products | 1 | 2022 | 934 | 0.420 |
Why?
|
Nervous System Diseases | 3 | 2020 | 1664 | 0.400 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3859 | 0.400 |
Why?
|
Neuroglia | 1 | 2017 | 960 | 0.380 |
Why?
|
Middle Aged | 44 | 2024 | 223463 | 0.350 |
Why?
|
Motor Neurons | 6 | 2021 | 872 | 0.350 |
Why?
|
Job Satisfaction | 2 | 2024 | 549 | 0.350 |
Why?
|
Delayed Diagnosis | 1 | 2014 | 469 | 0.340 |
Why?
|
Osteoma, Osteoid | 1 | 2011 | 94 | 0.340 |
Why?
|
Internship and Residency | 2 | 2021 | 5948 | 0.320 |
Why?
|
Aged | 33 | 2024 | 171544 | 0.320 |
Why?
|
Adult | 41 | 2024 | 223622 | 0.320 |
Why?
|
Research | 1 | 2017 | 1981 | 0.320 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2277 | 0.310 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2005 | 1628 | 0.310 |
Why?
|
Male | 53 | 2024 | 364870 | 0.310 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3118 | 0.310 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3241 | 0.300 |
Why?
|
Muscular Diseases | 1 | 2012 | 554 | 0.300 |
Why?
|
Astrocytes | 4 | 2018 | 1349 | 0.300 |
Why?
|
Machado-Joseph Disease | 1 | 2008 | 26 | 0.300 |
Why?
|
DNA Repeat Expansion | 1 | 2008 | 74 | 0.290 |
Why?
|
Female | 49 | 2024 | 397050 | 0.290 |
Why?
|
Synapses | 2 | 2009 | 1766 | 0.280 |
Why?
|
Electromyography | 4 | 2018 | 1402 | 0.270 |
Why?
|
Carbon Radioisotopes | 2 | 2018 | 567 | 0.270 |
Why?
|
Research Design | 2 | 2022 | 6209 | 0.270 |
Why?
|
Delivery of Health Care | 4 | 2019 | 5375 | 0.260 |
Why?
|
Survival Analysis | 6 | 2023 | 10117 | 0.260 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15939 | 0.260 |
Why?
|
Spastic Paraplegia, Hereditary | 2 | 2021 | 171 | 0.250 |
Why?
|
Wnt Proteins | 1 | 2009 | 724 | 0.250 |
Why?
|
Neurofilament Proteins | 2 | 2024 | 337 | 0.250 |
Why?
|
Bibliometrics | 2 | 2019 | 355 | 0.250 |
Why?
|
Microsatellite Repeats | 1 | 2008 | 784 | 0.250 |
Why?
|
United States Food and Drug Administration | 2 | 2024 | 1672 | 0.240 |
Why?
|
Activities of Daily Living | 7 | 2023 | 2433 | 0.240 |
Why?
|
Hexosaminidases | 1 | 2024 | 45 | 0.240 |
Why?
|
Receptors, Cell Surface | 2 | 2005 | 2819 | 0.240 |
Why?
|
Ambulatory Care Facilities | 3 | 2021 | 940 | 0.240 |
Why?
|
Football | 2 | 2021 | 506 | 0.230 |
Why?
|
Neural Conduction | 2 | 2018 | 443 | 0.230 |
Why?
|
Hippocampus | 2 | 2009 | 3784 | 0.230 |
Why?
|
Travel | 2 | 2020 | 800 | 0.220 |
Why?
|
Shoulder Joint | 1 | 2011 | 749 | 0.220 |
Why?
|
Genetic Counseling | 1 | 2008 | 634 | 0.220 |
Why?
|
Body Mass Index | 2 | 2012 | 13050 | 0.220 |
Why?
|
Dyslipidemias | 1 | 2011 | 873 | 0.220 |
Why?
|
Spinal Cord | 3 | 2021 | 1813 | 0.220 |
Why?
|
United States | 16 | 2024 | 73144 | 0.220 |
Why?
|
Vitamin D | 1 | 2017 | 3311 | 0.210 |
Why?
|
Hand | 3 | 2020 | 912 | 0.210 |
Why?
|
Qualitative Research | 2 | 2024 | 3131 | 0.210 |
Why?
|
Radiculopathy | 2 | 2018 | 203 | 0.210 |
Why?
|
Linoleic Acids | 1 | 2022 | 39 | 0.210 |
Why?
|
CD40 Ligand | 1 | 2024 | 524 | 0.210 |
Why?
|
Neurites | 1 | 2005 | 390 | 0.210 |
Why?
|
Neurons | 3 | 2009 | 9512 | 0.200 |
Why?
|
Riluzole | 1 | 2022 | 61 | 0.200 |
Why?
|
Inosine | 1 | 2023 | 129 | 0.200 |
Why?
|
Drugs, Investigational | 1 | 2024 | 213 | 0.200 |
Why?
|
Curriculum | 3 | 2021 | 3775 | 0.190 |
Why?
|
Positron-Emission Tomography | 4 | 2018 | 6670 | 0.190 |
Why?
|
Esters | 1 | 2022 | 212 | 0.190 |
Why?
|
Spinal Cord Injuries | 2 | 2020 | 929 | 0.190 |
Why?
|
Brain | 7 | 2021 | 27452 | 0.190 |
Why?
|
Sex Characteristics | 1 | 2012 | 2661 | 0.190 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2015 | 12239 | 0.180 |
Why?
|
Glycosylation | 1 | 2004 | 1100 | 0.180 |
Why?
|
Quality of Life | 8 | 2022 | 13499 | 0.180 |
Why?
|
Patient Care Team | 3 | 2019 | 2529 | 0.180 |
Why?
|
Phenylenediamines | 1 | 2021 | 88 | 0.180 |
Why?
|
Huntington Disease | 1 | 2007 | 1147 | 0.170 |
Why?
|
Quality Improvement | 3 | 2020 | 3858 | 0.170 |
Why?
|
Administration, Inhalation | 2 | 2023 | 1169 | 0.170 |
Why?
|
Lower Extremity | 2 | 2021 | 1218 | 0.170 |
Why?
|
Health Services Accessibility | 3 | 2024 | 5511 | 0.170 |
Why?
|
Elbow Joint | 1 | 2023 | 359 | 0.170 |
Why?
|
Home Care Services | 2 | 2020 | 659 | 0.170 |
Why?
|
Cromolyn Sodium | 1 | 2019 | 78 | 0.160 |
Why?
|
Industry | 1 | 2021 | 365 | 0.160 |
Why?
|
Carbamates | 1 | 2021 | 192 | 0.160 |
Why?
|
Antioxidants | 2 | 2018 | 1673 | 0.160 |
Why?
|
Intention to Treat Analysis | 1 | 2020 | 417 | 0.160 |
Why?
|
Cooking | 1 | 2021 | 312 | 0.160 |
Why?
|
Frontotemporal Lobar Degeneration | 1 | 2020 | 102 | 0.160 |
Why?
|
Cytoskeleton | 1 | 2004 | 1176 | 0.160 |
Why?
|
Receptors, GABA | 2 | 2018 | 313 | 0.160 |
Why?
|
Endpoint Determination | 1 | 2022 | 594 | 0.160 |
Why?
|
Time | 1 | 2020 | 546 | 0.160 |
Why?
|
Wheelchairs | 2 | 2020 | 78 | 0.160 |
Why?
|
Pyrazines | 1 | 2024 | 1206 | 0.160 |
Why?
|
Sick Leave | 1 | 2019 | 105 | 0.150 |
Why?
|
Imidazoles | 1 | 2024 | 1168 | 0.150 |
Why?
|
Geographic Information Systems | 1 | 2020 | 283 | 0.150 |
Why?
|
Bone Neoplasms | 1 | 2011 | 2565 | 0.150 |
Why?
|
Pamphlets | 1 | 2018 | 71 | 0.150 |
Why?
|
Baseball | 1 | 2019 | 95 | 0.150 |
Why?
|
Computers, Handheld | 1 | 2020 | 211 | 0.150 |
Why?
|
Enteral Nutrition | 3 | 2020 | 804 | 0.150 |
Why?
|
Caregivers | 4 | 2019 | 2303 | 0.150 |
Why?
|
Fatty Acids | 2 | 2023 | 1817 | 0.150 |
Why?
|
Proportional Hazards Models | 4 | 2023 | 12557 | 0.150 |
Why?
|
Behavior | 1 | 2020 | 543 | 0.150 |
Why?
|
Education, Distance | 1 | 2021 | 261 | 0.140 |
Why?
|
Interneurons | 1 | 2002 | 593 | 0.140 |
Why?
|
Adaptation, Psychological | 2 | 2021 | 2661 | 0.140 |
Why?
|
Nerve Tissue Proteins | 2 | 2008 | 4414 | 0.140 |
Why?
|
Cost of Illness | 2 | 2019 | 1959 | 0.140 |
Why?
|
Time Factors | 7 | 2023 | 40267 | 0.140 |
Why?
|
Survival | 1 | 2017 | 160 | 0.140 |
Why?
|
Athletes | 2 | 2021 | 1162 | 0.140 |
Why?
|
Acetamides | 1 | 2018 | 260 | 0.140 |
Why?
|
Myofibrils | 1 | 2017 | 143 | 0.140 |
Why?
|
Sodium Chloride | 1 | 2018 | 584 | 0.130 |
Why?
|
Survival Rate | 3 | 2017 | 12870 | 0.130 |
Why?
|
Running | 1 | 2021 | 490 | 0.130 |
Why?
|
Rehabilitation | 1 | 2017 | 131 | 0.130 |
Why?
|
Protein Processing, Post-Translational | 1 | 2004 | 1967 | 0.130 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2018 | 269 | 0.130 |
Why?
|
Review Literature as Topic | 1 | 2018 | 353 | 0.130 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2106 | 0.130 |
Why?
|
Benzothiazoles | 1 | 2016 | 248 | 0.130 |
Why?
|
Muscle Weakness | 2 | 2019 | 415 | 0.120 |
Why?
|
Shoulder | 1 | 2017 | 301 | 0.120 |
Why?
|
Arm | 2 | 2023 | 590 | 0.120 |
Why?
|
Treatment Outcome | 7 | 2024 | 65365 | 0.120 |
Why?
|
Pandemics | 5 | 2022 | 8750 | 0.120 |
Why?
|
Central Nervous System | 1 | 2002 | 1346 | 0.120 |
Why?
|
Respiratory Insufficiency | 1 | 2023 | 1241 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2024 | 10776 | 0.120 |
Why?
|
Physicians | 2 | 2023 | 4614 | 0.120 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 2015 | 165 | 0.120 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2014 | 45 | 0.120 |
Why?
|
Housing | 1 | 2019 | 680 | 0.120 |
Why?
|
Tracheostomy | 2 | 2019 | 436 | 0.110 |
Why?
|
Muscle Strength | 1 | 2018 | 641 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10377 | 0.110 |
Why?
|
Vital Capacity | 3 | 2024 | 984 | 0.110 |
Why?
|
Drug Combinations | 1 | 2020 | 2078 | 0.110 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2226 | 0.110 |
Why?
|
Self-Help Devices | 1 | 2014 | 62 | 0.110 |
Why?
|
Cost Savings | 1 | 2019 | 915 | 0.110 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2023 | 1398 | 0.110 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2021 | 3781 | 0.110 |
Why?
|
Patient Selection | 3 | 2021 | 4265 | 0.110 |
Why?
|
Physician's Role | 1 | 2020 | 926 | 0.110 |
Why?
|
Costs and Cost Analysis | 1 | 2019 | 1669 | 0.110 |
Why?
|
Diagnosis, Differential | 4 | 2019 | 13019 | 0.110 |
Why?
|
Orthotic Devices | 1 | 2014 | 131 | 0.110 |
Why?
|
Hospice Care | 1 | 2020 | 679 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 6 | 2021 | 36849 | 0.110 |
Why?
|
Retrospective Studies | 7 | 2023 | 81768 | 0.110 |
Why?
|
Spinal Muscular Atrophies of Childhood | 1 | 2014 | 115 | 0.100 |
Why?
|
Ganglion Cysts | 1 | 2012 | 27 | 0.100 |
Why?
|
Terminal Care | 2 | 2015 | 1773 | 0.100 |
Why?
|
Glycogen Storage Disease Type II | 1 | 2012 | 43 | 0.100 |
Why?
|
Ulnar Neuropathies | 1 | 2012 | 32 | 0.100 |
Why?
|
Animals | 11 | 2022 | 169322 | 0.100 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2003 | 3612 | 0.100 |
Why?
|
Biomedical Research | 3 | 2024 | 3464 | 0.100 |
Why?
|
Young Adult | 8 | 2021 | 60048 | 0.100 |
Why?
|
Metabolome | 1 | 2019 | 1008 | 0.100 |
Why?
|
Psychotic Disorders | 1 | 2007 | 3279 | 0.100 |
Why?
|
Publishing | 1 | 2019 | 836 | 0.100 |
Why?
|
Parkinson Disease | 3 | 2017 | 2893 | 0.100 |
Why?
|
Pilot Projects | 3 | 2021 | 8730 | 0.100 |
Why?
|
Complementary Therapies | 1 | 2015 | 487 | 0.090 |
Why?
|
Ambulatory Care | 2 | 2019 | 2784 | 0.090 |
Why?
|
Polyneuropathies | 1 | 2012 | 139 | 0.090 |
Why?
|
Counseling | 1 | 2019 | 1553 | 0.090 |
Why?
|
Wrist | 1 | 2012 | 232 | 0.090 |
Why?
|
Educational Measurement | 1 | 2018 | 1256 | 0.090 |
Why?
|
Antibodies, Monoclonal | 2 | 2024 | 9261 | 0.090 |
Why?
|
Thiazolidinediones | 1 | 2013 | 461 | 0.090 |
Why?
|
Osteoarthritis | 1 | 2018 | 1070 | 0.090 |
Why?
|
Pyridines | 2 | 2021 | 2889 | 0.090 |
Why?
|
Muscular Dystrophies | 1 | 2012 | 393 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1812 | 0.090 |
Why?
|
Acceleration | 1 | 2011 | 190 | 0.090 |
Why?
|
Pain Measurement | 1 | 2020 | 3579 | 0.080 |
Why?
|
Neck | 1 | 2014 | 736 | 0.080 |
Why?
|
Cells, Cultured | 5 | 2018 | 19019 | 0.080 |
Why?
|
Dermatomyositis | 1 | 2012 | 266 | 0.080 |
Why?
|
Program Evaluation | 1 | 2018 | 2505 | 0.080 |
Why?
|
Motor Cortex | 2 | 2017 | 1014 | 0.080 |
Why?
|
Databases, Factual | 2 | 2017 | 8072 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2020 | 5311 | 0.080 |
Why?
|
Personal Satisfaction | 2 | 2023 | 647 | 0.080 |
Why?
|
Cerebral Cortex | 2 | 2021 | 5830 | 0.080 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1469 | 0.080 |
Why?
|
Musculoskeletal Diseases | 1 | 2014 | 601 | 0.070 |
Why?
|
Follow-Up Studies | 7 | 2021 | 39405 | 0.070 |
Why?
|
Dendritic Spines | 1 | 2009 | 244 | 0.070 |
Why?
|
Diffusion Tensor Imaging | 1 | 2018 | 2426 | 0.070 |
Why?
|
Mortality | 1 | 2019 | 2917 | 0.070 |
Why?
|
Registries | 2 | 2021 | 8378 | 0.070 |
Why?
|
Muscle Contraction | 1 | 2012 | 1208 | 0.070 |
Why?
|
Monitoring, Ambulatory | 1 | 2011 | 357 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3252 | 0.070 |
Why?
|
Brain Concussion | 1 | 2019 | 1433 | 0.070 |
Why?
|
Single-Blind Method | 2 | 2023 | 1585 | 0.070 |
Why?
|
Dendrites | 1 | 2009 | 472 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2018 | 3139 | 0.070 |
Why?
|
Actigraphy | 1 | 2011 | 526 | 0.070 |
Why?
|
Walking | 1 | 2014 | 1201 | 0.070 |
Why?
|
Cell Line | 3 | 2018 | 15593 | 0.070 |
Why?
|
Physical Examination | 1 | 2012 | 1262 | 0.070 |
Why?
|
Prospective Studies | 5 | 2022 | 54921 | 0.070 |
Why?
|
Mice | 7 | 2019 | 82004 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 15455 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2019 | 3627 | 0.070 |
Why?
|
Hand Strength | 2 | 2020 | 466 | 0.070 |
Why?
|
Accidental Falls | 1 | 2014 | 1080 | 0.060 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2820 | 0.060 |
Why?
|
Prognosis | 2 | 2017 | 30020 | 0.060 |
Why?
|
Bayes Theorem | 2 | 2024 | 2353 | 0.060 |
Why?
|
Postoperative Complications | 1 | 2007 | 15854 | 0.060 |
Why?
|
Regression Analysis | 1 | 2014 | 6350 | 0.060 |
Why?
|
Biosensing Techniques | 1 | 2011 | 661 | 0.060 |
Why?
|
Data Collection | 3 | 2020 | 3324 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4209 | 0.060 |
Why?
|
Stress Fibers | 1 | 2004 | 55 | 0.060 |
Why?
|
RNA, Untranslated | 1 | 2008 | 457 | 0.060 |
Why?
|
Hydrazones | 1 | 2024 | 105 | 0.060 |
Why?
|
Phalloidine | 1 | 2003 | 21 | 0.060 |
Why?
|
Clinical Competence | 1 | 2019 | 4847 | 0.050 |
Why?
|
Pediatrics | 1 | 2019 | 3624 | 0.050 |
Why?
|
Radiography, Interventional | 1 | 2011 | 1131 | 0.050 |
Why?
|
Torque | 1 | 2023 | 133 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 4047 | 0.050 |
Why?
|
Biotinylation | 1 | 2003 | 185 | 0.050 |
Why?
|
Elbow | 1 | 2023 | 130 | 0.050 |
Why?
|
Cohort Studies | 5 | 2021 | 41791 | 0.050 |
Why?
|
Dystroglycans | 1 | 2002 | 62 | 0.050 |
Why?
|
Mice, Neurologic Mutants | 1 | 2002 | 107 | 0.050 |
Why?
|
Subcellular Fractions | 1 | 2003 | 527 | 0.050 |
Why?
|
Muscle, Skeletal | 2 | 2012 | 4981 | 0.050 |
Why?
|
Receptors, Neurotransmitter | 1 | 2002 | 174 | 0.050 |
Why?
|
Oligonucleotides, Antisense | 1 | 2005 | 461 | 0.050 |
Why?
|
Incidence | 4 | 2022 | 21544 | 0.050 |
Why?
|
Point Mutation | 1 | 2007 | 1595 | 0.050 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2023 | 225 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12092 | 0.050 |
Why?
|
Immunohistochemistry | 3 | 2004 | 11117 | 0.050 |
Why?
|
Morpholines | 1 | 2024 | 584 | 0.050 |
Why?
|
Butyrates | 1 | 2022 | 168 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2024 | 794 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 3108 | 0.040 |
Why?
|
Ciprofloxacin | 1 | 2022 | 313 | 0.040 |
Why?
|
Comorbidity | 1 | 2015 | 10588 | 0.040 |
Why?
|
Presynaptic Terminals | 1 | 2002 | 302 | 0.040 |
Why?
|
Immunoblotting | 1 | 2003 | 1647 | 0.040 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2001 | 256 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2023 | 542 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2020 | 59683 | 0.040 |
Why?
|
Israel | 1 | 2022 | 727 | 0.040 |
Why?
|
Tubulin | 1 | 2003 | 694 | 0.040 |
Why?
|
Muscle Spasticity | 1 | 2020 | 159 | 0.040 |
Why?
|
Neuromuscular Junction Diseases | 1 | 2019 | 14 | 0.040 |
Why?
|
Adolescent | 4 | 2021 | 89182 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2005 | 1078 | 0.040 |
Why?
|
Vitamin E | 1 | 2024 | 874 | 0.040 |
Why?
|
Respiration, Artificial | 2 | 2023 | 2721 | 0.040 |
Why?
|
Pyrimidines | 2 | 2024 | 3048 | 0.040 |
Why?
|
Palliative Care | 1 | 2014 | 3643 | 0.040 |
Why?
|
Mastication | 1 | 2019 | 53 | 0.040 |
Why?
|
Psychological Tests | 1 | 2021 | 643 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 4120 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2004 | 12801 | 0.040 |
Why?
|
Morphogenesis | 1 | 2002 | 747 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2021 | 22292 | 0.040 |
Why?
|
Neurotransmitter Agents | 1 | 2002 | 665 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 14154 | 0.040 |
Why?
|
Microtubules | 1 | 2004 | 1073 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2021 | 678 | 0.040 |
Why?
|
Ventilators, Mechanical | 1 | 2020 | 292 | 0.040 |
Why?
|
Cadherins | 1 | 2002 | 905 | 0.040 |
Why?
|
Embryo, Mammalian | 1 | 2003 | 1674 | 0.040 |
Why?
|
Catheter Ablation | 1 | 2011 | 2776 | 0.040 |
Why?
|
Advisory Committees | 1 | 2021 | 797 | 0.040 |
Why?
|
Craniocerebral Trauma | 1 | 2021 | 495 | 0.030 |
Why?
|
Neuromuscular Junction | 1 | 2019 | 407 | 0.030 |
Why?
|
Risk Factors | 3 | 2021 | 74954 | 0.030 |
Why?
|
Spirometry | 1 | 2020 | 928 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 2018 | 521 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2002 | 1337 | 0.030 |
Why?
|
Risk | 2 | 2019 | 9635 | 0.030 |
Why?
|
Actins | 1 | 2004 | 2059 | 0.030 |
Why?
|
Logistic Models | 2 | 2021 | 13323 | 0.030 |
Why?
|
Certification | 1 | 2019 | 420 | 0.030 |
Why?
|
Equipment Design | 2 | 2017 | 3529 | 0.030 |
Why?
|
Telephone | 1 | 2019 | 630 | 0.030 |
Why?
|
Movement | 2 | 2015 | 1490 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4584 | 0.030 |
Why?
|
RNA Interference | 1 | 2005 | 2836 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2002 | 1614 | 0.030 |
Why?
|
Alleles | 1 | 2007 | 6892 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2002 | 3101 | 0.030 |
Why?
|
Bradycardia | 1 | 2017 | 305 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2022 | 1894 | 0.030 |
Why?
|
Axons | 1 | 2003 | 1678 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 997 | 0.030 |
Why?
|
Cell Survival | 1 | 2005 | 5792 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2023 | 2143 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2020 | 810 | 0.030 |
Why?
|
Aspartic Acid | 1 | 2017 | 577 | 0.030 |
Why?
|
Levodopa | 1 | 2015 | 223 | 0.030 |
Why?
|
Atrophy | 1 | 2020 | 1648 | 0.030 |
Why?
|
Antiparkinson Agents | 1 | 2015 | 184 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1837 | 0.030 |
Why?
|
Signal Transduction | 2 | 2009 | 23629 | 0.030 |
Why?
|
Glutamine | 1 | 2017 | 578 | 0.030 |
Why?
|
Speech | 1 | 2019 | 558 | 0.030 |
Why?
|
Pyrazoles | 1 | 2024 | 2021 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2019 | 904 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18358 | 0.030 |
Why?
|
Decision Making | 2 | 2019 | 3953 | 0.030 |
Why?
|
Observer Variation | 1 | 2019 | 2623 | 0.030 |
Why?
|
Resilience, Psychological | 1 | 2021 | 804 | 0.030 |
Why?
|
Child | 2 | 2019 | 80894 | 0.030 |
Why?
|
Spinal Cord Compression | 1 | 2014 | 234 | 0.020 |
Why?
|
Advance Care Planning | 1 | 2019 | 698 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2201 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2002 | 3712 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2017 | 1193 | 0.020 |
Why?
|
Athletic Injuries | 1 | 2021 | 1245 | 0.020 |
Why?
|
Peptides | 1 | 2003 | 4352 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2021 | 1923 | 0.020 |
Why?
|
PPAR gamma | 1 | 2013 | 487 | 0.020 |
Why?
|
Italy | 1 | 2012 | 854 | 0.020 |
Why?
|
Clothing | 1 | 2011 | 96 | 0.020 |
Why?
|
Fatigue | 1 | 2017 | 1555 | 0.020 |
Why?
|
Stroke | 1 | 2012 | 9742 | 0.020 |
Why?
|
International Cooperation | 1 | 2016 | 1438 | 0.020 |
Why?
|
Metabolomics | 1 | 2019 | 1675 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9681 | 0.020 |
Why?
|
Lipids | 1 | 2020 | 3344 | 0.020 |
Why?
|
Self Report | 1 | 2021 | 3766 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3111 | 0.020 |
Why?
|
Cause of Death | 1 | 2019 | 3728 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2011 | 848 | 0.020 |
Why?
|
Rats | 1 | 2004 | 23833 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20224 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20766 | 0.020 |
Why?
|
Phenotype | 1 | 2005 | 16716 | 0.020 |
Why?
|
Models, Statistical | 1 | 2021 | 5099 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2022 | 9618 | 0.020 |
Why?
|
Apoptosis | 1 | 2001 | 9506 | 0.010 |
Why?
|
Cytokines | 1 | 2019 | 7443 | 0.010 |
Why?
|
Anxiety | 1 | 2019 | 4675 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2001 | 11914 | 0.010 |
Why?
|
Brain Mapping | 1 | 2018 | 6740 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10863 | 0.010 |
Why?
|
Sex Factors | 1 | 2016 | 10656 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2018 | 9063 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22355 | 0.010 |
Why?
|
Replication Origin | 1 | 2001 | 77 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 2001 | 239 | 0.010 |
Why?
|
Simian virus 40 | 1 | 2001 | 292 | 0.010 |
Why?
|
Vimentin | 1 | 2001 | 257 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2001 | 866 | 0.010 |
Why?
|
Depression | 1 | 2019 | 8241 | 0.010 |
Why?
|
Obesity | 1 | 2021 | 13082 | 0.010 |
Why?
|
Cell Transplantation | 1 | 2001 | 474 | 0.010 |
Why?
|
Clone Cells | 1 | 2001 | 1671 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 26373 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14736 | 0.010 |
Why?
|
Muscle Proteins | 1 | 2001 | 1165 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2011 | 14783 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 30230 | 0.010 |
Why?
|
Down-Regulation | 1 | 2001 | 2937 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15652 | 0.010 |
Why?
|
Transfection | 1 | 2001 | 5758 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2001 | 5800 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2001 | 11659 | 0.000 |
Why?
|